➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Colorcon
Harvard Business School
Merck
Baxter
Medtronic

Last Updated: January 22, 2021

DrugPatentWatch Database Preview

Litigation Details for Alkermes Pharma Ireland Limited v. Mylan Pharmaceuticals Inc. (D. Del. 2012)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Alkermes Pharma Ireland Limited v. Mylan Pharmaceuticals Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial , and   Start Trial .

Details for Alkermes Pharma Ireland Limited v. Mylan Pharmaceuticals Inc. (D. Del. 2012)

Date Filed Document No. Description Snippet Link To Document
2012-12-06 1 United States Patent Nos. 6,228,398 (“the ’398 patent”) and 6,730,325 (“the ’325 patent”). This action…certification with respect to the ’398 patent constituted infringement of that patent. This is an exceptional case…certification with respect to the ’325 patent constituted infringement of that patent. This is an exceptional case… than the expiration dates of the ’398 patent and ’325 patent, including any extensions; …action is based upon the Patent Laws of the United States, 35 U.S.C. § 100 et seq. Case 1:12-cv-01673 External link to document
2014-05-19 27 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,228,398 B1; 6,730,325 B2. (… 2012 19 May 2014 1:12-cv-01673 830 Patent None District Court, D. Delaware External link to document
2012-12-06 4 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,228,398 B1; 6,730,325 B2;. … 2012 19 May 2014 1:12-cv-01673 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
AstraZeneca
Mallinckrodt
Baxter
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.